Cocaine use entails severe health-and social-related harms globally. Treatment options for
cocaine dependence are highly limited. Benefits of cannabinoids for addiction have been …

Rationale The growing prevalence of psychostimulant (including amphetamine) use and
associated health harms, with limited treatment options, present a global challenge. There is …

Background Cannabinoids may have an important therapeutic potential for the treatment of
dependence on crack cocaine. Cannabidiol (CBD), in particular, has anxiolytic …

Various countries and US States have legalized cannabis, and the use of the psychoactive1
and non-psychoactive cannabinoids is steadily increasing. In this review, we have collated …

Crack-cocaine use is prevalent in numerous countries, yet concentrated primarily–largely
within urban contexts–in the Northern and Southern regions of the Americas. It is associated …

Background Cannabinoids are proposed in a wide array of medical indications. Yet, the
evaluation of adverse effects in controlled clinical studies, following the evidence‐based …

In many communities, cannabis is perceived as a low-risk drug, leading to political lobbying
to decriminalise its use. Acute and chronic cannabis use has been shown to be harmful to …

Adverse effects related to cannabis are an emerging health risk exemplified by reliable
increases in calls to poison control centers and emergency department visits due to both …

Increased public access to cannabis calls for a deeper understanding of cannabis's
constituents and how they interact to induce clinical effects. Whereas trans‐Δ9 …

Cannabis (also known as marijuana) is the most frequently used illicit psychoactive
substance in the world. Though it was long considered to be a “soft” drug, studies have …